Who cares who is presenting the results. This is what’s in the 11am- 11:15 time slot though
11:00 AM - 11:15 AM A Phase 3 Study of Isradipine as a Disease Modifying Agent in Patients with Early Parkinson’s disease (STEADY-PD III): Final Study Results Tanya Simuni MD